Ultrafast circulating breast tumor DNA detection in blood by CRISPR/dCas9 biosensor

被引：0
|
作者：
Uygun, Z. O. [1 ]
Yeniay, L. [2 ]
Sagin, F. [1 ]
机构：
[1] Ege Univ, Dept Med Biochem, Fac Med, Izmir, Turkey
[2] Ege Univ, Dept Gen Surg, Fac Med, Izmir, Turkey
来源：
FEBS OPEN BIO | 2021年 / 11卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P-05.3-01
引用
收藏
页码：279 / 279
页数：1
相关论文
共 50 条
  • [1] Crispr/dCas9 and gene activation
    Akinci, Ersin
    Unal, Pelin
    Badakul, Gamze
    Yildiz, Mehmet
    JOURNAL OF BIOTECHNOLOGY, 2017, 256 : S42 - S42
  • [2] CRISPR-dCas9 powered impedimetric biosensor for label-free detection of circulating tumor DNAs
    Uygun, Zihni Onur
    Yeniay, Levent
    Sagin, Ferhan Girgin
    ANALYTICA CHIMICA ACTA, 2020, 1121 : 35 - 41
  • [3] Activating PTEN Tumor Suppressor Expression with the CRISPR/dCas9 System
    Moses, Colette
    Nugent, Fiona
    Waryah, Charlene Babra
    Garcia-Bloj, Benjamin
    Harvey, Alan R.
    Blancafort, Pilar
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2019, 14 : 287 - 300
  • [4] Transcriptional regulation by CRISPR/dCas9 in common wheat
    Zhou, Huajie
    Xu, Lei
    Li, Feng
    Li, Yansha
    GENE, 2022, 807
  • [5] Application of Various Delivery Methods for CRISPR/dCas9
    Liu, Zhixi
    Liao, Zhi
    Chen, Yan
    Han, Lizhu
    Yin, Qinan
    Xiao, Hongtao
    MOLECULAR BIOTECHNOLOGY, 2020, 62 (08) : 355 - 363
  • [6] Epigenetic editing by CRISPR/dCas9 in Plasmodium falciparum
    Xiao, Bo
    Yin, Shigang
    Hu, Yang
    Sun, Maoxin
    Wei, Jieqiong
    Huang, Zhenghui
    Wen, Yuhao
    Dai, Xueyu
    Chen, Huiling
    Mu, Jianbing
    Cui, Liwang
    Jiang, Lubin
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, 116 (01) : 255 - 260
  • [7] Application of Various Delivery Methods for CRISPR/dCas9
    Zhixi Liu
    Zhi Liao
    Yan Chen
    Lizhu Han
    Qinan Yin
    Hongtao Xiao
    Molecular Biotechnology, 2020, 62 : 355 - 363
  • [8] CRISPR/dCas9 for hepatic fibrosis therapy: implications and challenges
    Luo, Nianan
    Zhong, Wenjun
    Li, Jiangbin
    Lu, Jianguo
    Dong, Rui
    MOLECULAR BIOLOGY REPORTS, 2022, 49 (12) : 11403 - 11408
  • [9] CRISPR/dCas9 for hepatic fibrosis therapy: implications and challenges
    Nianan Luo
    Wenjun Zhong
    Jiangbin Li
    Jianguo Lu
    Rui Dong
    Molecular Biology Reports, 2022, 49 : 11403 - 11408
  • [10] Activation of pluripotency genes using CRISPR/dCas9 system
    Vilarino, M.
    Meckler, J.
    Segal, D. J.
    Ross, J. P.
    TRANSGENIC RESEARCH, 2016, 25 (01) : 116 - 116
12345